HIF1A and ischemic disease: ,49,50 The increased HIF-1α driven glycolytic flux, which is commonly accompanied by increased lactate concentrations, is often a problem per se in pathophysiological conditions such as inflammation, infection (Covid-19), ischemic diseases as infarct and stroke, and also in tumor development and progression.